Clinical Trial Update: Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study [NA]

View source ↗

Summary

This clinical trial update describes a pharmacokinetic study evaluating Busulfan and Fludarabine as conditioning before allogeneic stem cell transplantation for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Alberta Health services | Conditions: Hematologic Malignancy | NA | Status: UNKNOWN